ARCL Organics appoints Deepak Daga as company secretary
- ARCL Organics Ltd appoints Deepak Daga as Company Secretary and Compliance Officer
- Appointment effective September 16, 2026, approved by the Board of Directors
- Move ensures compliance with Companies Act 2013 and SEBI LODR regulations
- Mr. Daga is an ICSI Associate Member with no shareholding or director relations

*this image is generated using AI for illustrative purposes only.
ARCL Organics Ltd appointed Deepak Daga as its Company Secretary and Compliance Officer effective September 16, 2026. The appointment was approved by the Board of Directors during a meeting held on the same date.
The decision aligns with Section 203 of the Companies Act, 2013 and Regulation 6 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. Mr. Daga brings experience in corporate and secretarial matters to the role.
Appointment Details
Mr. Daga is an Associate Member of the Institute of Company Secretaries of India (ICSI), holding membership number 50346. He holds no shareholding in the company and has no relationship with any existing directors.
| Particulars | Details |
|---|---|
| Name | Deepak Daga |
| Designation | Company Secretary & Compliance Officer |
| Effective Date | September 16, 2026 |
| Shareholding | Nil |
| Director Relationship | None |
The Board meeting commenced at 10:15 am and concluded at 10:45 am. The appointment follows a recommendation from the Nomination & Remuneration Committee. Terms and conditions for the role will be decided by the board.
Historical Stock Returns for ARCL Organics Ltd
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| +5.00% | +22.49% | +16.54% | +16.54% | +16.54% | +16.54% |
How might Deepak Daga's appointment influence ARCL Organics' compliance strategy and regulatory risk management in the coming fiscal year?
What specific corporate governance initiatives or restructuring plans might the Board be preparing that necessitated this new compliance leadership?
Could this appointment signal upcoming strategic shifts, such as potential mergers, acquisitions, or IPO preparations for ARCL Organics?


































